3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Myelodysplastic Syndromes
15
Multiple Myeloma
12
Lymphoma, B-Cell
8
Recurrence
7
Ovarian Neoplasms
7
Lymphoma, Non-Hodgkin
7
Lymphoma
7
Burkitt Lymphoma
6
Hodgkin Disease
5
Pancreatic Neoplasms
4
Myeloproliferative Disorders
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Biphenotypic, Acute
4
Leukemia
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urogenital Neoplasms
3
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Osteosarcoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hematologic Neoplasms
3
Graft vs Host Disease
3
Gastrointestinal Neoplasms
3
Breast Neoplasms
3
Interventions
pembrolizumab
7
Specimen Handling
6
Human Papillomavirus DNA Tests
4
Colposcopy
4
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Fulvestrant
3
Cisplatin
3
Carboplatin
3
palbociclib
2
lenvatinib
2
Surveys and Questionnaires
2
Radiation Dose Hypofractionation
2
Nivolumab
2
Magnetic Resonance Imaging
2
Gemcitabine
2
Biopsy
2
Bevacizumab
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
tisotumab vedotin
1
sapanisertib
1
ribociclib
1
relatlimab
1
pertuzumab
1
patritumab deruxtecan
1
osimertinib
1
omipalisib
1
liposomal doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
fludarabine
×
30 days
×
Clear all
No trials found.